Skip to content

Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease

Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04949750
Enrollment
70
Registered
2021-07-02
Start date
2022-09-01
Completion date
2025-06-30
Last updated
2026-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease

Keywords

Early Alzheimer Disease, Paper - based cognitive training, Randomized trial

Brief summary

The purpose of this study is to assess the efficacy of paper-based cognitive training in Vietnamese patients with early Alzheimer's disease

Interventions

OTHERPaper - based cognitive training

Cognitive training

Sponsors

University of California, Davis
CollaboratorOTHER
National Geriatric Hospital
CollaboratorOTHER_GOV
National Institute on Aging (NIA)
CollaboratorNIH
University of Medicine and Pharmacy at Ho Chi Minh City
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* For patient: * Diagnosis of Probable Alzheimer's Disease per DSM-5 criteria; * In the early stage of AD (MMSE from 20 to 25); * Age from 60 - 80 years old; * Had greater than 5 years of formal education. * For Caregiver: * Members (including, but not limited to partners, children, relatives, lived-in helper of the patient) that are important for care delivery and provide care-related tasks (eg personal care, eating, cooking, cleaning) and everyday decision making to the patients. They are not required to live together or spend a specific amount of time with the patients; * Older than 18 years of age; * Possess adequate Vietnamese language skills and no cognitive impairment to conduct interview and evaluation

Exclusion criteria

* For patient: * Patients with concomitant diseases (heart failure, kidney failure, liver failure or thyroid diseases) that affect cognitive functions; * Diagnosed with significant neurologic disease other than AD (Parkinson's disease, multi-infarct dementia, schizophrenia, history of significant head trauma followed by persistent neurologic defaults, …), major depression within the past 1 year, or taking psychoactive medications (antidepressants with significant anticholinergic side effects, neuroleptics, chronic anxiolytics or sedative hypnotics, etc) within the past 1 month; * Having major visual, auditory, reading, or writing impairments; * Patients and/or caregivers who decline to participate. * For cargiver: * Having subjective complaints of cognitive impairment prevents them from understanding the instruction from the research team; * Having significant visual, auditory, reading, or writing impairments; * Caregivers who decline to participate

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in the Instrumental Activities of Daily Living (IADL) score.12 weeks from baseline cognitive assessmentInstrumental Activities of Daily Living (IADL) is a questionnaire to assess patient's capacity to live independently.
Change from baseline in the Clock drawing test12 weeks from baseline cognitive assessment1-6 points, with higher scores indicating worse visuo-spatial function.
Change from baseline in the 15-Item Version of the Boston Naming Test12 weeks from baseline cognitive assessmentCognitive test of semantic memory. Object naming to confrontation, which also depends upon intact perceptual and word retrieval ability. Higher scores indicating better cognition.
Change from baseline in the Mini-Mental State Examination (MMSE)12 weeks from baseline cognitive assessmentIt is a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment. The score is between 0-30. Higher score indicating better cognition.
Change from baseline in the Memory tests12 weeks from baseline cognitive assessmentImmediate Recall, Delayed Recall, Delayed Recognition are tests that measure memory function. Higher score indicating better cognition.
Change from baseline in the Trail Making test scores12 weeks from baseline cognitive assessmentRaw score, assessing attention, executive function. TMT is divided into two parts, TMT-A and TMT-B. In the TMT part A, circles with number from 1 to 25 are arranged randomly. Numerical sequence should be connected by patients as quickly as possible, cutoff value \> 180 seconds. In the TMT part B, patients must alternate between numbers and letters, cut off value \> 300 second. Cutoff scores indicate the value above suggest cognitive performance is normal.
Change from baseline in the Digits Span forward and backward12 weeks from baseline cognitive assessmentThe longest digits of forward and backward are 8 and 7, respectively. The total scores are twelve for each test. Higher score indicating better cognition.
Change from baseline in the Verbal fluency test12 weeks from baseline cognitive assessmentSemantic memory score will be measured using the Verbal fluency test. The verbal fluency test is a short test of verbal functioning. Participants are given 1 min to produce as many animals as possible within a semantic category (category fluency). The participant's score is the number of animals. Higher score means better cognition.

Secondary

MeasureTime frameDescription
Percentage of participants completes the full 12-week cognitive training.12 weeks from baseline cognitive assessmentEvery 4 weeks participants will follow-up at Dementia Center and be able to continue the training if they complete 80% of each level of difficulty workload. Therefore, we aim to calculate the percentage of participants who can completes the full 12-week cognitive training.
Change from baseline in the Zarit Burden Interview (ZBI) score.12 weeks from baseline cognitive assessmentZarit Burden Interview score is a questionnaire to assess patient's caregiver burden.

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026